Tullman Stephen A. 4
4 · Aclaris Therapeutics, Inc. · Filed Aug 27, 2018
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Purchase
Common Stock
2018-08-23$15.00/sh+6,600$98,985→ 170,357 total
Holdings
- 394,014(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018.
- [F2]These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.